← All trials

NCT07079631

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jul 18, 2025
Primary completion
Dec 31, 2030
Completion date
May 31, 2031
First posted
Jul 23, 2025
Last posted
Oct 27, 2025
Enrollment
482
Arms / groups
6 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.